Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Women Birth ; 37(1): 98-105, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-37827892

RESUMO

OBJECTIVE: To scope and synthesise literature around the job satisfaction of early career midwives - those in their first five years of post-qualification practice - including the effect on their career aspirations and intention to leave the profession. DESIGN: Scoping review. METHODS: Relevant databases were searched for published research studies and grey literature. Literature were selected through adherence to pre-set inclusion and exclusion criteria to ensure relevance. Literature was included that was published from 2012. Selected literature were tabled and common themes were mapped to look for similarities and differences in findings. FINDINGS: Ten papers were included - seven original research studies, a fact sheet, a non peer-reviewed article, and a conference paper. Negative themes - lack of support, workload stress, and job dissatisfaction, and positive themes - passion for midwifery, collegial relationships, and autonomy - were found across many of the included papers. KEY CONCLUSIONS: Many midwives are considering leaving their profession due to the stress of their work, role dissatisfaction, and a lack of support. This is more common amongst early career midwives. There were some protective factors such as having pride in the midwifery profession. More research is needed to identify and address the needs specific to early career midwives.


Assuntos
Tocologia , Enfermeiros Obstétricos , Gravidez , Humanos , Feminino , Satisfação no Emprego , Intenção , Objetivos
2.
J Infect Dis ; 199(4): 486-93, 2009 Feb 15.
Artigo em Inglês | MEDLINE | ID: mdl-19125676

RESUMO

BACKGROUND: Shiga toxin (Stx)-producing Escherichia coli (STEC), especially O157:H7, cause bloody diarrhea, and in 3%-15% of individuals the infection leads to hemolytic uremic syndrome (HUS) or other complications. Use of antibiotics to treat STEC infections is controversial. Here, we describe the use of piglets to evaluate the efficacy and mechanism of action of antibiotics in these infections. METHODS: The effects of 2 antibiotics on STEC toxin production and their mechanisms of action were first determined by enzyme-linked immunosorbent assay and subsequently evaluated clinically in the gnotobiotic piglet infection model. RESULTS: In vitro treatment of clinical and isogenic strains with ciprofloxacin increased the production of Stx2 via phage induction but not the production of Stx1. Azithromycin caused no significant increase in toxin production. After treatment with ciprofloxacin, infected piglets had diarrhea and the severe fatal neurological symptoms associated with Stx2 intoxication. Characteristic petechial hemorrhages in the cerebellum were more severe in ciprofloxacin-treated animals than in control animals. In contrast, azithromycin-treated piglets survived the infection and had little or no brain hemorrhaging. CONCLUSIONS: The increased in vitro toxin production caused by ciprofloxacin was strongly correlated with death and an increased rate of cerebellar hemorrhage, in contrast to the effect of azithromycin. The piglet is a suitable model for determining the effectiveness and safety of antibiotics available to treat patients.


Assuntos
Antibacterianos/uso terapêutico , Azitromicina/uso terapêutico , Ciprofloxacina/uso terapêutico , Infecções por Escherichia coli/tratamento farmacológico , Escherichia coli O157/efeitos dos fármacos , Vida Livre de Germes , Análise de Variância , Animais , Antibacterianos/efeitos adversos , Antibacterianos/farmacologia , Azitromicina/efeitos adversos , Azitromicina/farmacologia , Cerebelo/patologia , Distribuição de Qui-Quadrado , Ciprofloxacina/efeitos adversos , Ciprofloxacina/farmacologia , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Infecções por Escherichia coli/microbiologia , Infecções por Escherichia coli/patologia , Escherichia coli O157/genética , Escherichia coli O157/metabolismo , Mutação , Recombinases Rec A/genética , Toxina Shiga I/metabolismo , Toxina Shiga II/análise , Toxina Shiga II/metabolismo , Análise de Sobrevida , Suínos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA